NASDAQ:GTH Genetron (GTH) Stock Price, News & Analysis → Musk’s new company could top a trillion? (From Paradigm Press) (Ad) Free GTH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.02▼$4.0550-Day Range$3.85▼$4.0352-Week Range$2.08▼$4.05Volume412,600 shsAverage Volume51,662 shsMarket Capitalization$127.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesOwnershipShort InterestTrendsStock AnalysisHeadlinesOwnershipShort InterestTrends Get Genetron alerts: Email Address Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. About Genetron Stock (NASDAQ:GTH)Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.Read More Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. GTH Stock News HeadlinesMarch 29, 2024 | finanznachrichten.deGenetron Holdings Limited: Genetron Health Announces Completion of Going Private TransactionMarch 28, 2024 | globenewswire.comGenetron Health Announces Completion of Going Private TransactionFebruary 21, 2024 | finanznachrichten.deGenetron Holdings Limited: Genetron Health Announces Shareholders' Approval of Merger AgreementFebruary 21, 2024 | finance.yahoo.comGenetron Health Announces Shareholders’ Approval of Merger AgreementFebruary 21, 2024 | globenewswire.comGenetron Health Announces Shareholders' Approval of Merger AgreementFebruary 14, 2024 | fool.comGenetron (NASDAQ: GTH)February 14, 2024 | wsj.comGenetron Holdings Ltd. ADRJanuary 17, 2024 | finance.yahoo.comGenetron Health to Hold Extraordinary General Meeting of ShareholdersJanuary 9, 2024 | seekingalpha.comAlbertsons-Kroger And 15 Other Merger Arbitrage Opportunities With Wide SpreadsJanuary 9, 2024 | seekingalpha.comGenetron Holdings' Enticing Arbitrage ReturnNovember 24, 2023 | morningstar.comGenetron Holdings Ltd ADR GTHOctober 12, 2023 | finanznachrichten.deGenetron Holdings Limited: Genetron Health Enters into Definitive Merger Agreement for Going Private TransactionOctober 12, 2023 | msn.comStocks Rise Before the Open as U.S. Inflation Data LoomsOctober 12, 2023 | msn.comStocks Climb Before the Open as Bond Yields Fall, U.S. Inflation Data LoomsOctober 11, 2023 | finance.yahoo.comGenetron Health Enters into Definitive Merger Agreement for Going Private TransactionMay 24, 2023 | msn.comGenetron Health receives Nasdaq notice for non-complianceMarch 27, 2023 | msn.comAmerican Depositary Receipts of Asian Stocks Lower Amid Banking Sector WorriesJanuary 18, 2023 | finance.yahoo.comGenetron Health Regains Compliance With Nasdaq Minimum Bid Price RequirementDecember 28, 2022 | msn.comEarlier US Stock Market Losses Weighed on Asian EquitiesNovember 7, 2022 | finance.yahoo.comGenetron Health Announces Receipt of Notification from NasdaqOctober 19, 2022 | seekingalpha.comGTH Genetron Holdings LimitedOctober 12, 2022 | finance.yahoo.comGenetron Health Reports Unaudited Second Quarter 2022 Financial ResultsSeptember 20, 2022 | reuters.comGenetron Holdings LtdSeptember 2, 2022 | finance.yahoo.comGenetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special CommitteeAugust 22, 2022 | benzinga.comGenetron Health Announces Receipt of a...See More Headlines Receive GTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/23/2021Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolNASDAQ:GTH CUSIPN/A CIK1782594 Webwww.genetronhealth.com Phone86-10-5090-7500FaxN/AEmployees993Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$94.34 million Price / Sales1.35 Cash FlowN/A Price / Cash FlowN/A Book Value$2.63 per share Price / Book1.53Miscellaneous Outstanding Shares31,620,000Free FloatN/AMarket Cap$127.43 million OptionableNot Optionable Beta0.51 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Sizhen Wang (Age 47)Co-Founder, CEO & Chairman Dr. Wei-Wu He Ph.D. (Age 59)Co-Founder & Chairman Emeritus Dr. Hai Yan M.D. (Age 56)Ph.D., Co-Founder, Chief Scientific Officer & Director Mr. Ce Xu (Age 42)Chief Financial Officer Ms. Victoria LeiChief Operating OfficerDr. Yuchen Jiao M.D. (Age 46)Ph.D., Chief Technology Officer Mr. Yong Liang (Age 50)Chief Human Resources Officer Dr. Yun-Fu Hu Ph.D. (Age 61)Chief Medical Officer Ms. Lily LiuChief Commercial OfficerMore ExecutivesKey CompetitorsBurning Rock BiotechNASDAQ:BNRBiodesixNASDAQ:BDSXPersonalisNASDAQ:PSNLbioAffinity TechnologiesNASDAQ:BIAFWPrenetics GlobalNASDAQ:PRENWView All CompetitorsInstitutional OwnershipVirtu Financial LLCBought 30,385 shares on 5/20/2024Ownership: 0.096%Black Maple Capital Management LPBought 137,054 shares on 5/16/2024Ownership: 0.933%View All Institutional Transactions GTH Stock Analysis - Frequently Asked Questions How were Genetron's earnings last quarter? Genetron Holdings Limited (NASDAQ:GTH) released its quarterly earnings results on Sunday, May, 23rd. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by $0.30. The business earned $14.05 million during the quarter. Read the conference call transcript. When did Genetron's stock split? Genetron's stock reverse split before market open on Thursday, October 26th 2023. The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. When did Genetron IPO? Genetron (GTH) raised $162 million in an initial public offering on Friday, June 19th 2020. The company issued 13,000,000 shares at $11.50-$13.50 per share. Credit Suisse and CICC served as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers. Who are Genetron's major shareholders? Genetron's stock is owned by a variety of institutional and retail investors. Top institutional investors include Black Maple Capital Management LP (0.93%) and Virtu Financial LLC (0.10%). This page (NASDAQ:GTH) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetron Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.